three subjects were withdrawn from the auranofin-treated group ( increasing severity of rheumatoid arthritis at four weeks ; severe diarrhea at four weeks ; probable drug-related erosive gastritis at 40 weeks ) .
C0004320
auranofin
C0003873
rheumatoid arthritis